• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    89bio, Inc. - Common Stock (NQ: ETNB )

    7.985 +0.045 (+0.57%)
    Streaming Delayed Price Updated: 2:30 PM EST, Dec 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 522,824
    Open 7.800
    Bid (Size) 7.980 (3)
    Ask (Size) 7.990 (9)
    Prev. Close 7.940
    Today's Range 7.650 - 8.030
    52wk Range 6.430 - 16.63
    Shares Outstanding 75,480,884
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From 89bio, Inc.
    Via GlobeNewswire
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From 89bio, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -29.27%
    -29.27%
    1 Month
    -10.88%
    -10.88%
    3 Month
    +7.61%
    +7.61%
    6 Month
    +9.23%
    +9.23%
    1 Year
    -28.32%
    -28.32%

    More News

    Read More
    89bio to Participate in the 7th Annual Evercore HealthCONx Conference
    From 89bio, Inc.
    Via GlobeNewswire
    ETNB Stock Earnings: 89bio Beats EPS for Q2 2024
    Via InvestorPlace
    89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024
    From 89bio, Inc.
    Via GlobeNewswire
    89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants
    From 89bio, Inc.
    Via GlobeNewswire
    89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
    From 89bio, Inc.
    Via GlobeNewswire
    89bio Reports Third Quarter 2024 Financial Results and Corporate Updates
    From 89bio, Inc.
    Via GlobeNewswire
    89bio to Participate in the UBS Global Healthcare Conference
    From 89bio, Inc.
    Via GlobeNewswire
    Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
    Via Investor's Business Daily
    89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024
    From 89bio, Inc.
    Via GlobeNewswire
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From 89bio, Inc.
    Via GlobeNewswire
    89bio to Participate in the H.C. Wainwright 8th Annual MASH Investor Conference
    From 89bio, Inc.
    Via GlobeNewswire
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From 89bio, Inc.
    Via GlobeNewswire
    89bio Announces Appointment of Teresa Perney, Ph.D. as Chief Regulatory and Quality Officer
    From 89bio, Inc.
    Via GlobeNewswire
    89bio to Participate in Upcoming Investor Conferences
    From 89bio, Inc.
    Via GlobeNewswire
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From 89bio, Inc.
    Via GlobeNewswire
    89bio Appoints Francis Sarena as Chief Operating Officer
    From 89bio, Inc.
    Via GlobeNewswire
    89bio Reports Second Quarter 2024 Financial Results and Corporate Updates
    From 89bio, Inc.
    Via GlobeNewswire
    89bio Appoints Charles McWherter, Ph.D., to its Board of Directors
    From 89bio, Inc.
    Via GlobeNewswire
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From 89bio, Inc.
    Via GlobeNewswire
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From 89bio, Inc.
    Via GlobeNewswire
    What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
    Via Benzinga
    Madrigal, Akero, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH
    Via Investor's Business Daily
    The Week Ahead: What's Next
    Via Talk Markets
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.